The World Health Organization (WHO) released its Global Tuberculosis Report 2015 today, announcing that tuberculosis (TB) caused 1.5 million deaths in 2014, and HIV/AIDS caused 1.2 million deaths last year1.
Rockville, MD, July 20, 2015 – David L. Blumberg, M.B.A., an expert in the life sciences industry, recently joined Aeras’s Board of Directors. He has more than 20 years of business and consulting experience across the life sciences continuum, including large global, specialty, and generic pharmaceuticals, biotech, and medical devices and products.
Aeras announced today a new leadership structure for the nonprofit biotech organization with Jacqueline E. Shea, Ph.D., the current Chief Operating Officer (COO), assuming the role of Chief Executive Officer (CEO), effective August 12. Thomas G. Evans, M.D., will step down as CEO to become Acting Chief Scientific Officer (CSO). Ann M. Ginsberg, M.D., Ph.D., will continue as Chief Medical Officer.
Aeras, IDT Biologika Form a Strategic Partnership with Acquisition of Aeras’s Manufacturing Facility
Aeras and IDT Biologika today announced a strategic partnership that includes the acquisition of Aeras’s Biopharmaceutical Development Center (BDC) manufacturing facility by IDT.
Aeras is pleased to announce that Dara Erck joins the organization today as the Vice President of External Affairs. As a member of the senior leadership team, Ms. Erck will be responsible for resource mobilization, advocacy, and communications.